This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA

Michael Sadick, Ph.D.
Senior Director at Precision Biosciences


Dr. Sadick is Principal Scientist at Catalent Biological Analytical Services, in Morrisville, NC. There he coordinates and oversees Bioassay, ELISA and Molecular Biology projects. Previously, he managed the Bioassay/Relative Potency team, for 10 years, at Catalent Biologics in Kansas City, MO (formerly Aptuit, Inc). Prior to that, Mike worked for 6 years at Eli Lilly and Co. as a Research Advisor leading the Bioassay Groups, Molecular Biology and Virology in support of Phase I-III projects, as well as providing guidance for commercial bioassay testing. Before his tenure at Eli Lilly, Dr. Sadick ran bioassay groups for 10 years at Genentech in South San Francisco. Dr. Sadick has an extensive background in cellular biology, cellular immunology and receptor signaling, molecular biology and biochemistry. He received his MS and Ph.D. in immunology from University of Washington in Seattle, and his BA in biology from Johns Hopkins, in Baltimore.

Agenda Sessions

  • Connecting the dots - How to connect primary and working reference standards when your therapeutic is a cellular (CAR T) product